Aktive Positionen von Mike Wood
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| VERNALIS | Technik-/Wissenschafts-/F&E-Leiter | 01.02.2004 | - |
Vernalis (R&D) Ltd.
 Vernalis (R&D) Ltd. Pharmaceuticals: MajorHealth Technology Vernalis (R&D) Ltd. engages in the research development of biotechnology and pharmaceutical products manufacturing. The company was founded on February 4, 1986 and is headquartered in Wokingham, the United Kingdom. | Vorstandsvorsitzender | 01.01.2019 | - |
Karriereverlauf von Mike Wood
Ehemalige bekannte Positionen von Mike Wood
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| RiboTargets Ltd. | Corporate Officer/Principal | - | - |
Statistik
International
| Vereinigtes Königreich | 4 |
Operativ
| Chief Tech/Sci/R&D Officer | 1 |
| Corporate Officer/Principal | 1 |
| Chief Executive Officer | 1 |
Sektoral
| Health Technology | 4 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
Ligand UK Ltd.
 Ligand UK Ltd. Pharmaceuticals: MajorHealth Technology Ligand UK Ltd. is a commercial stage pharmaceutical company. Its products include Tuzistra XR, targeting the U.S. prescription cough-cold market, Moxatag, a once-a-day formulation of the antibiotic and amoxicillin, and frovatriptan, used for the acute treatment of migraine. It also develops and commercializes multiple novel products focused on the U.S. prescription cough-cold market. The company was founded by Keith G. McCullagh and Andre L. Lamotte in 1988 and is headquartered in Winnersh, the United Kingdom. | Health Technology |
| RiboTargets Ltd. | Health Technology |
Vernalis (R&D) Ltd.
Vernalis (R&D) Ltd. Pharmaceuticals: MajorHealth Technology Vernalis (R&D) Ltd. engages in the research development of biotechnology and pharmaceutical products manufacturing. The company was founded on February 4, 1986 and is headquartered in Wokingham, the United Kingdom. | Health Technology |
